EP2780029A4 - Formulations orales de leptine et leurs utilisations - Google Patents
Formulations orales de leptine et leurs utilisationsInfo
- Publication number
- EP2780029A4 EP2780029A4 EP11875859.8A EP11875859A EP2780029A4 EP 2780029 A4 EP2780029 A4 EP 2780029A4 EP 11875859 A EP11875859 A EP 11875859A EP 2780029 A4 EP2780029 A4 EP 2780029A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- oral
- leptin formulations
- leptin
- formulations
- oral leptin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000016267 Leptin Human genes 0.000 title 1
- 108010092277 Leptin Proteins 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 title 1
- 229940039781 leptin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2235—Secretins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA2011/050720 WO2013071396A1 (fr) | 2011-11-18 | 2011-11-18 | Formulations orales de leptine et leurs utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2780029A1 EP2780029A1 (fr) | 2014-09-24 |
EP2780029A4 true EP2780029A4 (fr) | 2015-06-24 |
Family
ID=48428867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11875859.8A Withdrawn EP2780029A4 (fr) | 2011-11-18 | 2011-11-18 | Formulations orales de leptine et leurs utilisations |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2780029A4 (fr) |
CA (1) | CA2855545A1 (fr) |
WO (1) | WO2013071396A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017532292A (ja) * | 2014-08-11 | 2017-11-02 | オルバニー メディカル カレッジ | ミリストイル化レプチン関連ペプチド及びその使用 |
AU2022244505A1 (en) * | 2021-03-23 | 2023-02-09 | Kashiv Biosciences, Llc | An extraction process of pancrelipase and evaluation threof |
CN115463094B (zh) * | 2021-06-10 | 2023-07-04 | 北京微著新材科技有限公司 | 一种口服放疗防护剂及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060045869A1 (en) * | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
WO2006133333A2 (fr) * | 2005-06-07 | 2006-12-14 | The Rockefeller University | Stimulation de proliferation de lymphocytes pancreatiques b |
WO2007109354A2 (fr) * | 2006-03-21 | 2007-09-27 | Amylin Pharmaceuticals, Inc. | Conjugués inhibiteur de peptidase-peptide et procédés d'utilisation de ceux-ci |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8268791B2 (en) * | 2004-08-25 | 2012-09-18 | Aegis Therapeutics, Llc. | Alkylglycoside compositions for drug administration |
EP2470197A4 (fr) * | 2009-08-24 | 2013-03-13 | Aegis Therapeutics Llc | Composition pour l absorption et l action prolongée de peptides liés à la leptine |
-
2011
- 2011-11-18 WO PCT/CA2011/050720 patent/WO2013071396A1/fr active Application Filing
- 2011-11-18 EP EP11875859.8A patent/EP2780029A4/fr not_active Withdrawn
- 2011-11-18 CA CA2855545A patent/CA2855545A1/fr not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060045869A1 (en) * | 2004-08-25 | 2006-03-02 | Aegis Therapeutics Llc | Absorption enhancers for drug administration |
WO2006133333A2 (fr) * | 2005-06-07 | 2006-12-14 | The Rockefeller University | Stimulation de proliferation de lymphocytes pancreatiques b |
WO2007109354A2 (fr) * | 2006-03-21 | 2007-09-27 | Amylin Pharmaceuticals, Inc. | Conjugués inhibiteur de peptidase-peptide et procédés d'utilisation de ceux-ci |
Non-Patent Citations (1)
Title |
---|
See also references of WO2013071396A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2780029A1 (fr) | 2014-09-24 |
WO2013071396A1 (fr) | 2013-05-23 |
CA2855545A1 (fr) | 2013-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI559936B (en) | Oral care compositions | |
HK1183802A1 (en) | Therapeutic oral composition | |
ZA201206666B (en) | Oral care composition | |
HUE033071T2 (hu) | Vakcinakészítmények | |
SG11201401056SA (en) | Oral care compositions | |
AU2012398397A8 (en) | Oral care composition | |
ZA201206301B (en) | Oral care composition | |
ZA201205804B (en) | Oral care compositions | |
PT2605757E (pt) | Formulações à base de nalbufina e suas utilizações | |
HK1203432A1 (en) | Oral care compositions | |
ZA201206068B (en) | Oral care compositions | |
HK1203402A1 (en) | Oral care compositions | |
PL2555829T3 (pl) | Kompozycje do pielęgnacji jamy ustnej | |
HK1183228A1 (zh) | 口服藥物治療方法和組合物 | |
ZA201404443B (en) | Oral care compositions | |
HK1200705A1 (en) | Oral care compositions | |
ZA201305285B (en) | Oral care compositions | |
HK1203385A1 (en) | Oral care compositions | |
HK1198137A1 (en) | Disinfecting formulations and uses thereof | |
EP2734194A4 (fr) | Formulations de soin buccal | |
EP2780029A4 (fr) | Formulations orales de leptine et leurs utilisations | |
HK1203386A1 (en) | Oral care compositions | |
EP2533762A4 (fr) | Formulations de rétinol et procédés pour leur utilisation | |
EP2531180A4 (fr) | Composition complexe orale comprenant la pseudoéphédrine et la lévocétirizine | |
HK1200100A1 (en) | Oral care composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20140527 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RA4 | Supplementary search report drawn up and despatched (corrected) |
Effective date: 20150522 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/56 20060101ALI20150518BHEP Ipc: A61K 38/05 20060101ALI20150518BHEP Ipc: A23L 1/30 20060101ALI20150518BHEP Ipc: C07K 14/81 20060101ALI20150518BHEP Ipc: A61K 9/00 20060101ALI20150518BHEP Ipc: C07K 14/575 20060101ALI20150518BHEP Ipc: A61P 3/00 20060101ALI20150518BHEP Ipc: A61K 38/57 20060101ALI20150518BHEP Ipc: A61K 38/22 20060101AFI20150518BHEP Ipc: A61K 31/575 20060101ALI20150518BHEP Ipc: A61K 45/06 20060101ALI20150518BHEP Ipc: A61K 31/203 20060101ALI20150518BHEP Ipc: A61K 38/28 20060101ALI20150518BHEP Ipc: A61K 31/198 20060101ALI20150518BHEP Ipc: C07K 7/02 20060101ALI20150518BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20151222 |